The Native Antigen Company



Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for studying emerging diseases. The Native Antigen Company are a leading supplier of native and recombinant viral and bacterial antigens, antibodies and immunoassays, alongside bespoke custom and contract services. Its infectious disease reagents are widely adopted by pharmaceutical, in vitro diagnostics and vacc.... Read more

SARS-COV-2 NUCLEOPROTEIN, HIS-TAG (E. COLI) SARS-CoV-2 Nucleoprotein (E. coli...

SARS-COV-2 SPIKE GLYCOPROTEIN (S2) SARS-CoV-2 Spike S2, His-tag is a recombin...

SARS-COV-2 SPIKE-E-M MOSAIC PROTEIN, HIS-TAG (E. COLI) SARS-CoV-2 Spike-E-M M...

HUMAN CORONAVIRUS 229E NUCLEOPROTEIN Human Coronavirus 229E Nucleoprotein is ...

HUMAN CORONAVIRUS NL63 NUCLEOPROTEIN Human Coronavirus NL63 Nucleoprotein is ...

Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for studying emerging diseases.

The Native Antigen Company are a leading supplier of native and recombinant viral and bacterial antigens, antibodies and immunoassays, alongside bespoke custom and contract services. Its infectious disease reagents are widely adopted by pharmaceutical, in vitro diagnostics and vaccine manufacturers, as well as leading academic groups in cutting-edge research, where correct folding and glycosylation of proteins is vital. We also offer our expertise on a contract basis to other sectors where highly purified proteins are required. It is an ethical and sustainable organisation and are proud of the long-term relationships with customers and partners.